The status of the organism Gaffkya tetragena (Micrococcus tetragenus) among pathogens is uncertain at this time. Several reports (3, 14, 22, 24, 25, 27, 29) illustrate the ability of this organism to cause a variety of pathological conditions in man. Other reports (2, 15, 23, 27, 28) indicate variability in the pathogenicity among some strains of this organism for man and laboratory animals.
Although sufficient information is known about the organism to make identification possible and practicable, Mock and Wynne (11) and Reimann (14) Serial mouse passage. Virulent strains of G. tetragena were subjected to serial mouse passage to aid in the determination of component(s) associated with virulence. Growth from a 48-hr blood-agar plate was suspended in 10 ml of sterile 0.85% saline and dispersed. This suspension (1 ml) was injected intraperitoneally into several 5-to 6-week-old Swiss Webster white mice from an inbred colony. Organisms were recovered by aseptically opening the peritoneal cavity immediately after the mice had died, and streaking some of the exudate on a blood-agar plate. A pure culture of the passed organism was obtained after suitable incubation, and the process was repeated for each subsequent passage.
Determination of LD50. LD5 determinations were performed by the intraperitoneal injection of 1 ml of twofold, serially diluted, saline suspensions of viable cells of each strain into several 5-to 6-week-old white mice. Deaths were recorded for 1 week. Standard plate counts of each undiluted cell suspension were performed at the time of injection in duplicate in Trypticase Soy Agar. From the resulting deaths and the original cell counts, the LD50 for each strain was calculated by the method of Reed and Muench (13) .
Toxicity testing of cellular fractions and determination of lesion index. All purified cellular fractions were tested for toxicity by the intradermal injection of a known quantity of material in an 0.1-ml volume of sterile distilled water in the shaved flanks of 2.5-to 3.5-kg New Zealand albino rabbits, as described by Schwab and Cromartie (19) , Abdulla and Schwab (1) , and Schuster, Hayashi, and Bahn (18) . Quantitation of material prnor to injection was achieved by dry weight determinations of the material dried to a constant weight at 90 C.
The response of cellular fractions was recorded as a lesion index, which was determined by measuring the major and minor axis of the lesion in millimeters, taking the square root of the product of the two and adding one point each for erythema, hardness, thickness, and pus formation. These lesion indexes were determined daily for the first week of the test, then every other day for an additional 3 weeks.
Preparation of capsular material. Capsular material was obtained by the sodium acetate-ethyl alcohol extraction procedure, described by Kabat (8) , from a cell-free aqueous extract obtained by blending 5 g (dry weight) of whole cells in 100 ml of sterile distilled water for 10 min at high speed in a Waring Blendor. Deproteinization was accomplished by the phenolwater extraction method of Westphal, Luderitz, and Bister (26) . The capsular material was reprecipitated by a second sodium acetate-ethyl alcohol extraction and resuspended in sterile distilled water. Residual phenol was removed by extraction with anhydrous ethyl ether. Residual ether was removed by evaporation. The material was subjected to a spectrographic scan from 400 to 200 nm on a Beckman DB recording spectrophotometer; it was assayed for protein by the method of Lowry et al. (9) with crystalline bovine albumin as a standard, and by the method of Ikawa and Niemann (7) for total carbohydrate. Dry weights and sterility checks were performed, as on all other preparations, prior to toxicity testing.
Cell wall preparations. Modifications of the procedure of Roberson and Schwab (16) were used to prepare pure cell walls from all strains. Cells were ruptured with Ballotini glass beads in a 10-kc Raytheon sonic oscillator, followed by glycerol density gradient centrifugation. Crude cell walls were washed free of glycerol and were treated successively with 100 jAg of ribonuclease per ml and 200 ,ug of trypsin per ml at 37 C foi 3 hr.
Mucopeptide preparations. Preparations which were considered to be essentially mucopeptide were made from isolated cell walls by the formamide extraction method of Fuller (6), and from whole cells by the trichloroacetic acid extraction procedure of Park and Hancock (12) .
Preparation of grouplike substance. The supernatant fluid from the formamide mucopeptide extraction procedure was used to prepare grouplike material by the method of Fuller (6); this method is commonly employed for streptococci.
Cytoplasmic material. A fraction consisting of cytoplasmic material was obtained by sonic treatment of whole cells with glass beads so that 99.9% rupture of cells was achieved; collection of the supernatant fluid from centrifugation at 81,500 X g for 1 hr was carried out in a no. 40 rotor of a Spinco Model L ultracentrifuge.
Culture ifitrate. A cell-free culture filtrate was obtained from all strains by centrifuging a 72-hr Trypticase Soy Broth culture at 15,000 X g for 30 min in a refrigerated Sorvall centrifuge. The supernatant fluid was filtered through a 0.45-,um membrane filter (Millipore Corp., Bedford, Mass.). Toxicity tests were performed on these culture filtrates, and the filtrates were reduced by the addition (100 jug/ml) of cysteine to portions of the fluid prior to use.
Antisera. Antiserum to each of the organisms was prepared in rabbits by repeated intravenous injections of washed, Formalin-treated whole cells. RESULTS Initial characterization studies. All strains in this study were initially subjected to limited morphological and physiological testing to insure the use of strains typical of G. tetragena. The tetrad morphology exhibited by all strains in this study is typical for this species. Physiological tests, usually employed for members of the Micrococcaceae, were performed by standard methods on all strains in this study. All strains were uniformly negative for Fig. 2 . Similar results were obtained with capsular material from strains GT-7, 11, and 2 using as little as 10 jAg of material. The lesion produced by this material was of a soft, pustular nature that was less severe and of a shorter duration when compared to the hard, nodular lesions produced by whole cells. The lesion produced by capsular material remained pustular for 10 to 15 days, and then gradually subsided to scar formation within 22 days. Since toxic capsular material was found in the nonvirulent GT-2 strain, it is apparent that additional factors are essential to virulence. Since several studies (17, 18, 20) have shown the involvement of the cell wall of other grampositive cocci in toxicity, cell walls of all strains in this study were tested. Figure 3 shows the response of rabbit dermis to 100 ,ug (dry weight) of purified cell walls of all strains. The cell walls of the virulent strains are toxic, whereas those of the nonvirulent strains are not. The response produced by these toxic cell walls was the typical hard, nodular lesion previously described for whole cells. The response to strains GT-1 and 6 are no longer significant in this dermal toxicity testing and are placed in the nonvirulent group. The reason for the intermediate virulence response to GT-1 and 6 in the whole cell study is not known. The cell wall toxicity results are in excellent agreement with those obtained for the LD5O determination in relation to the virulence level of the various strains. The large differential response between the two groups of strains at day 7 should also be noted (Fig. 3) . Figure 4 shows, at day 7, the lesions from which the data were taken to plot the curves shown in Fig. 3 . The slight responses of cell walls from nonvirulent strains GT-1 to 5 are shown in Fig. 4A ; the large nodular lesions produced by cell walls of virulent strains GT-7, 8, and 11 are shown in Fig. 4B . The response to GT-6, not seen in Fig.  4A , was not different from those shown.
To study the possibility that a more basic unit of the cell wall, namely, the cell wall mucopeptide, might be involved in toxicity, two mucopeptide preparations were made from all strains and subjected to dermal toxicity testing: Figure 5 shows the results obtained from 100 Mg (dry weight) of formamide-prepared mucopeptide from pure cell walls. The mucopeptide from the virulent strains is toxic, whereas that of the nonvirulent strains is nontoxic. The response produced to the mucopeptide is identical to the hard, nodular lesion produced to whole cells and cell walls, althougti slightly less in severity and duration. Trichloroacetic acid-prepared mucopeptide from whole cells tested in the same manner yielded results analogous to those of the formamide mucopeptide. A slightly higher response to the trichloroacetic acid-extracted mucopeptide of the nonvirulent strains was noted. Compared by immunoelectrophoresis, each preparation showed a single precipitin band with homologous whole cell antiserum. The position of the bands for the virulent strains was slightly more toward the anode than was that from the nonvirulent strains.
Toxicity tests with the capsular material, cell walls, and mucopeptide preparations in mouse dermis gave identical differential responses from the various strains compared to rabbit dermis response; however, in all cases, the response in mice was greatly diminished and persisted for a shorter period of time.
Each of the fractions was tested for its ability to cause death in mice, as determined by the intraperitoneal injection of 1 ml of each fraction in the most concentrated stock solutions available. For purified cell walls and mucopeptide preparations, 2 to 4 mg/ml was injected. Capsular material was injected in the range of 100 to 500 gg/ml. week, no deaths were produced by any of these fractions. Mice were protected with homologous whole cell antiserum against a lethal challenge of viable cells. The dermal toxicity of capsular material was neutralized by this antiserum, but the dermal lesion induced by the mucopeptide was not altered. The remaining fractions subjected to toxicity testing were the cytoplasmic material, culture filtrate with and without added reducing agent, and the grouplike material from the formamide supernatant fluid. When these fractions from all strains were tested in rabbit and mouse dermis and intraperitoneally in mice, no toxicity for any fraction was demonstrated. The absence of toxicity from culture filtrates and cytoplasmic fractions of the virulent strains rules out the possibility of extra-or intracellular toxins associated with dermal toxicity under the conditions tested. The exact nature of the grouplike material isolated from the formamide supernatant fluid is unknown, but it appears that there is no group material in Gaffkya as is commonly thought of in relation to the streptococci. Failure of each of these extracts to react with specific, whole cell antisera supports this idea. gives added significance to the failure of repeated attempts to establish an LD5o for strains not possessing these two toxic components.
All strains lethal for mice were encapsulated, a state not remarkable in view of the known relation of capsules to virulence with Diplococcus pneumoniae serving as the best known example. This situation has been recognized in other organisms and recently reported by Bulmer and Sans (4) with encapsulated strains of Cryptococcus neoformans. Demonstration of dermal toxicity for capsular material was unexpected, and no reports of a similar capsular polysaccharide toxicity were found in the literature. The possibility exists that this capsular material may serve a dual role in the establishment of G. tetragena infection by allowing the organism to resist phagocytosis and by exerting a direct toxic effect itself upon the host.
Since strain GT-2 contained toxic capsular material but was nonvirulent, the importance of toxic cell wall mucopeptide in virulence is evident. The hard, nodular lesions produced in rabbit dermis to whole cells, cell walls, and cell wall mucopeptide of the virulent strains are very similar to those observed by Abdulla and Schwab (1) and Schuster et al. (18) under similar test conditions for streptococci and other gram-positive cocci. The extended duration of whole cell lesions compared to cell wall and mucopeptide lesions produced by the same amount of injected material in rabbit dermis may be related to particle size injected and rate of clearance of the material from the site of injection. Roberson, Schwab, and Cromartie (17) have shown that the size of lesion produced is related to particle size of cell wall complex injected; however, Schwab and Ohanian (21) have shown that the rate of elimination of injected streptococcal cell walls and mucopeptides is related to both properties of particle size and species from which these were derived. The prolonged response to whole cells may be due to a longer exposure to the toxic action because a longer period may be necessary for clearance from the injected site compared to that of the smaller cell wall and mucopeptide complexes.
It is unlikely that any other factor is responsible for the reaction in rabbit dermis other than the capsular material, cell walls, or mucopeptide preparations themselves. Hypersensitivity seems a highly unlikely mechanism of toxicity due to the regularity and predictability of the response which quickly follows injection of these materials into either normal rabbits or mice. This is also supported by the fact that while capsular material was neutralized in protection studies with the use of whole cell antisera, cell walls and mucopeptide preparations still induced lesions without modification in time of appearance, severity, or duration.
Preliminary chemical and immunological studies indicate that a complete, detailed chemical analysis of the capsule, cell walls, and cell wall mucopeptides of the strains in this study would aid greatly in defining toxicity in terms of exact chemical or structural features. Whether the mechanism of pathogenesis of G. tetragena in man is that of an opportunistic invader exerting its combined toxic effects under the protection of a capsule will require the analysis of additional isolates from hospital patients. A similar study performed on a wide variety of staphylococci and micrococci strains also would help to determine the exact taxonomic position and interrelationship of G. tetragena within the Micrococcaceae.
